QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

Help viewing high resolution images Return to article

Fig. 5. The molecular mass of T735E.TACE corresponds to mature TACE and is processed to maturity quicker than pro-WT.TACE. (A) COS-7 cells were transfected with 3 µg pcDNA3.1+ (lane U) or 3 µg pWT.TACE (lane NIgG and WT.TACE), pT735A.TACE (lane T735A.TACE) and pT735E.TACE (lane T735E.TACE). Cells transfected with pT735E.TACE were treated with 50 µM leupeptin for 18 hours after 6 hours of transfection. Twenty-four hours after transfection, the cells were lysed and TACE was immunoprecipitated using non-immune IgG antibodies (lane NIgG) or the anti-TACE ICD specific antibody. Immune complexes were washed with NP-40LB, and analysed by western blotting with the anti-TACE ICD antibody (C-15). (B) Similarly, 2x10⁶ WT.HeLa or untransfected HeLa cells were seeded overnight and TACE immunoprecipitated using the anti-TACE antibody (C-15). After extensively washing the immune complexes using NP-40LB they were analysed by western blotting using an anti-TACE antibody (C-15). (C) COS-7 cells were transfected with pWT.TACE, pT735A.TACE and pT735E.TACE and treated with 50 µM leupeptin for 18 hours after 6 hours of transfection. Cells were radiolabelled for 3 hours with [³⁵S]methionine/cysteine in the presence of 50 µM leupeptin, washed and chased in complete medium (lacking leupeptin) for the time indicated. TACE was purified and analysed by SDS-PAGE and autoradiography.

Return to article